
When the media repeatedly portrays such tepid ambivalence about psychotherapy, millions of suffering individuals get a vague and misleading impression of this treatment.

When the media repeatedly portrays such tepid ambivalence about psychotherapy, millions of suffering individuals get a vague and misleading impression of this treatment.

Children have real worries driven by real threats when it comes to climate change.

How can psychiatrists apply current ethical principles to war?

To image or not to image? Researchers performed a systematic review and meta-analysis of neuroradiological abnormalities in first-episode psychosis.

"During the past 5 years has gabapentin retained its position as one of the top 10 drugs prescribed in the United States."

One reader believes psychiatrists and mental health clinicians should approach climate change with skepticism.

Explore the mental health effects of voting.

How can we prevent retraumatization of vulnerable individuals and enable them to seek redress?

As many as 30% of your patients will experience treatment-resistant depression...

“Oates’ poems force us to reflect on the ethics of experimentation and to ask if the proverbial ends justify the means.”

"In regard to psychiatric hospitalizations, the principles of ethics are imperative in determining how to proceed in each case."

Suicidal individuals with depression likely have diminished capacity to provide informed consent for treatment as well as low perceived need for help.

These results were instrumental in securing the FDA approval of the drug for the treatment of schizophrenia in adults in April 2023.

Why aren't psychiatrists the answer?

New positive data for brexpiprazole, the first and only treatment approved to treat agitation associated with dementia due to Alzheimer disease.

What does it mean to receive crisis care in the typical emergency department? Psychiatrists have a powerful role in reducing boarding.

This book offers positivity via a unique form of poetry.

What are your gender pronouns?

From sleep and neuroendocrine function following TBI to new phase 3 results from a clinical trial evaluating a promising new schizophrenia treatment, here are highlights from the week in Psychiatric Times.

What is new in research on SUDs?

Is the world safe for our grandchildren?

Remembering Eugene Paykel, MD…

Sleep and neuroendocrine function are disrupted following TBI.

Researchers performed a head-to-head trial of vortioxetine versus desvenalfaxine in patients with depression and partial response to SSRIs.

Happy Halloween! To celebrate, Psychiatric Times® is looking back at our Scariest in Psychiatry series, which highlights clinicians’ most frightening, worrisome, and concerning issues in psychiatry.

Just because a patient has anxiety or past trauma does not mean they cannot enjoy this spooky holiday…

We must come together to find peace, says one doctor.

Researchers investigated associations between medications with potential depressive symptom adverse effects and the level of depressive symptoms in a large survey study. Here’s what they found.

The trial’s results showed statistically significant reductions in all major symptom domains and secondary endpoints.

Are you ready for Halloween? Who is your favorite slash killer of the horror genre and which psychiatric disorder could he meet criteria for?